Skip to main content
SpringerLink
Log in

Systemic Mastocytosis: Response to the Efficacy of Cladribine(2-CdA) with Current Terminology and Approach

  • Correspondence
  • Published:
Indian Journal of Hematology and Blood Transfusion Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Helbig G, Koclega A, Gaweł WB et al (2020) The efficacy of cladribine (2-CDA) in advanced systemic mastocytosis. Indian J Hematol Blood Transfus Grzegorz Helbig. https://doi.org/10.1007/s12288-020-01279-8

    Article  Google Scholar 

  2. Gotlib J, Gerds AT, Bose P et al (2018) Systemic mastocytosis, version 2.2019, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 16:1500–1537

    Article  Google Scholar 

  3. (2019) https://www.uptodate.com/contents/advanced-systemic-mastocytosis-management-and-prognosis. Accessed July 2020

  4. Pardanani A, Shah S, Mannelli F et al (2018) Mayo alliance prognostic system for mastocytosis: clinical and hybrid clinical-molecular models. Blood Adv 2:2964

    Article  CAS  Google Scholar 

  5. Jawhar M, Schwaab J, Álvarez-Twose I et al (2019) MARS: Mutation-adjusted risk score for advanced systemic mastocytosis. J Clin Oncol 37:2846

    Article  CAS  Google Scholar 

Download references

Funding

None.

Author information

Authors and Affiliations

  1. Division of Hematology, Adnan Menderes University Medical Faculty, Aytepe Location, 09010, Efeler, Aydın, Turkey

    Irfan Yavaşoğlu & Atakan Turgutkaya

Authors
  1. Irfan Yavaşoğlu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Atakan Turgutkaya
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Concept—I.Y., A.T., Design—A.T., I.Y.; Supervision—I.Y..; Resources—I.Y., A.T.; Materials—I.Y., A.T.; Data Collection and/or Processing—A.T., I.Y.,; Analysis and/or Interpretation–I.Y., A.T.; Literature Search—A.T.; Writing Manuscript—A.T.; Critical Review—I.Y., A.T.

Corresponding author

Correspondence to Atakan Turgutkaya.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yavaşoğlu, I., Turgutkaya, A. Systemic Mastocytosis: Response to the Efficacy of Cladribine(2-CdA) with Current Terminology and Approach. Indian J Hematol Blood Transfus 37, 329–330 (2021). https://doi.org/10.1007/s12288-020-01332-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12288-020-01332-6

Keywords

Search

Navigation